Protagonist Therapeutics Total Assets (Quarterly) Analysis

Protagonist Therapeutics Inc (PTGX)

25.55 -0.53 (-2.03%) USD | NASDAQ | Apr 17, 16:00

25.55 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	357.95M
September 30, 2023	330.02M
June 30, 2023	320.47M
March 31, 2023	239.86M
December 31, 2022	247.93M
September 30, 2022	282.17M
June 30, 2022	310.51M
March 31, 2022	348.30M
December 31, 2021	347.70M
September 30, 2021	373.18M
June 30, 2021	404.23M
March 31, 2021	298.07M
December 31, 2020	324.47M
September 30, 2020	217.32M
June 30, 2020	224.98M
March 31, 2020	134.90M
December 31, 2019	154.92M

Date	Value
September 30, 2019	154.63M
June 30, 2019	148.10M
March 31, 2019	132.25M
December 31, 2018	139.47M
September 30, 2018	148.86M
June 30, 2018	137.47M
March 31, 2018	149.24M
December 31, 2017	163.73M
September 30, 2017	110.42M
June 30, 2017	70.48M
March 31, 2017	82.67M
December 31, 2016	93.99M
September 30, 2016	102.84M
June 30, 2016	24.52M
March 31, 2016	31.86M
December 31, 2015	14.84M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

134.90M

Minimum

Mar 2020

404.23M

Maximum

Jun 2021

274.72M

Average

298.07M

Median

Mar 2021

Total Assets (Quarterly) Benchmarks

SELLAS Life Sciences Group Inc	6.219M
Arvinas Inc	1.305B
Akebia Therapeutics Inc	241.70M
Immuneering Corp	102.58M
Moderna Inc	18.43B

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	21.27M
Shareholders Equity (Quarterly)	336.68M
Current Ratio	16.71